MedTrace Logo

Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia

NCT05008874 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2025-10-30

No results posted yet for this study

Summary

The course of AMN-related disabilities over time is poorly or incompletely understood due to a limited number of patients and lack of treatments. This study will help obtain a better understanding of the progression of disease with AMN and facilitate efficient clinical development of future interventional medications.

Conditions

  • AMN
  • AMN Gene Mutation
  • X-ALD

Interventions

OTHER

Natural History Observation

Data collection on progression of disease

Sponsors & Collaborators

  • SwanBio Therapeutics, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-21
Primary Completion
2025-05-16
Completion
2025-05-16

Countries

  • United States
  • Germany
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05008874 on ClinicalTrials.gov